Search - tctmd.com

Displaying 1 - 13 of 13

Sort: Relevancy | Date

News Daily News

TCTMD’s Top 10 Most Popular Stories for April 2023

Shelley Wood

April 28, 2023

News Daily News

USPSTF: Most Vitamin, Supplement Data Still ‘Inconclusive’ on CVD Benefits

Yael L. Maxwell

June 23, 2022

News Daily News

HEP-COVID: Therapeutic-Dose Heparin Effective in Non-ICU Patients

Yael L. Maxwell

October 12, 2021

News Daily News

New Advanced Training Outlined for Future Vascular Medicine Specialists

Michael O'Riordan

January 21, 2021

News Daily News

US Mortality Rates for CVD Have Stalled as Racial Disparities Widen

Yael L. Maxwell

August 19, 2020

News Daily News

Higher Risk of HF After ACS for Women Previously on Beta-blockers

Michael O'Riordan

July 16, 2020

News Daily News

Anticoagulation Prescription in the ED May Boost Later Use

Todd Neale

December 11, 2019

News Daily News

Vasospasm, Microvascular Dysfunction Tied to MACE in Nonobstructive CAD

Michael O'Riordan

November 05, 2019

News Daily News

Baseline Ischemia Not Linked to 10-Year Events in Stable CAD: MASS II Analysis

Shelley Wood

July 23, 2019

News Daily News

Hospital Readmissions at 30 Days Declining for Stroke Patients

Michael O'Riordan

August 20, 2018

News Daily News

Generic ARBs Linked to Increased Adverse Events

Michael O'Riordan

October 04, 2017

News Daily News

$2 Billion Annual Price Tag for FOURIER-Eligible VA Patients on PCSK9 Inhibitor

Michael O'Riordan

May 12, 2017

News Daily News

Drugs Most Heavily Promoted by Pharma Don’t Necessarily Offer the Best Health Value

Todd Neale

May 04, 2017

Advertisement

TCTMD’s Top 10 Most Popular Stories for April 2023

USPSTF: Most Vitamin, Supplement Data Still ‘Inconclusive’ on CVD Benefits

HEP-COVID: Therapeutic-Dose Heparin Effective in Non-ICU Patients

New Advanced Training Outlined for Future Vascular Medicine Specialists

US Mortality Rates for CVD Have Stalled as Racial Disparities Widen

Higher Risk of HF After ACS for Women Previously on Beta-blockers

Anticoagulation Prescription in the ED May Boost Later Use

Vasospasm, Microvascular Dysfunction Tied to MACE in Nonobstructive CAD

Baseline Ischemia Not Linked to 10-Year Events in Stable CAD: MASS II Analysis

Hospital Readmissions at 30 Days Declining for Stroke Patients

Generic ARBs Linked to Increased Adverse Events

$2 Billion Annual Price Tag for FOURIER-Eligible VA Patients on PCSK9 Inhibitor

Drugs Most Heavily Promoted by Pharma Don’t Necessarily Offer the Best Health Value

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content